HIV News and Research

RSS

HIV epidemic in Moscow needs urgent measures

U.S. researchers say that HIV infection rates in vulnerable groups in Moscow could be between 30-120 times higher than those found in the general population.

4 Jul 2005

Progress on prison health prevented by political prejudice

An article in the Lancet says that measures to improve the health of prisoners should be based on evidence and not on political prejudice.

4 Jul 2005

HIV infection rates reaching epidemic proportion in Russia's vulnerable groups

HIV infection rates in vulnerable groups in Moscow could be between 30–120 times higher than those found in the general Russian Federation population, concludes a Research Letter.

4 Jul 2005

New law will take away vital medications from AIDS sufferers in Mississippi

Medicaid beneficiaries living with HIV/AIDS in Mississippi are about to be denied access to medications they need to stay alive.

1 Jul 2005

Report highlights importance of research into diseases in developing countries

Better drugs and vaccines are needed to fight HIV/AIDS, tuberculosis (TB), malaria and other tropical diseases. Pharmaceutical research has typically focussed on developing drugs, vaccines and other interventions for diseases prevalent in developed countries, where people can afford to buy treatments; it has tended to overlook those disorders that predominantly affect developing countries.

30 Jun 2005

Medicaid beneficiaries living with HIV/AIDS in Mississippi are about to be denied access to medications

A law that takes effect tomorrow, July 1, limits Mississippi Medicaid beneficiaries to two brand-name drugs. But controlling HIV infection requires three drugs, and all of them are brand name.

30 Jun 2005

Conservatives and sexual abstinence groups battle with FDA over condoms - they offer little protection against STD's

Although condoms are an effective method of contraception and stop the spread of AIDS, evidence that they protect against other sexually transmitted diseases is scant.

30 Jun 2005

New drug candidate against HIV-infection

As a part of a research collaboration, scientists at the Sahlgrenska Academy at Gotenborg University, Sweden, have developed a new drug candidate against HIV-infection. The new substance, named alphaHGA, will be tested on patients this year.

30 Jun 2005

If global efforts to prevent HIV/AIDS are to work long term, they must avoid suspicions of being unfair

Johns Hopkins infectious disease specialists who have spent more than two decades leading efforts to combat HIV and AIDS worldwide are warning that limited international relief supplies of antiretroviral therapies currently being distributed in Africa, Asia and the Caribbean will not get to those who can least afford to pay for them.

28 Jun 2005

Multi-million pound Grand Challenge grants to tackle TB and malaria in the developing world

UK scientists are to help tackle TB and malaria in the developing world through their leadership of two major international research projects.

28 Jun 2005

Grand Challenges in Global Health awards $450m to top scientists

Grants totalling U.S $450m were awarded yesterday to some of the world's most inventive scientists to enable them to turn their novel ideas into practical solutions to the 14 greatest problems plaguing human health today.

28 Jun 2005

Ethnicity makes little difference in the quality of outpatient care

A new study from the Stanford University School of Medicine has found that once U.S. patients visit a doctor for outpatient care, their race and ethnicity make little difference in the quality of care they receive.

28 Jun 2005

Gleevec or similar drugs might be useful in preventing adverse side effects of smallpox vaccine

Mice given a relatively new cancer drug can survive an otherwise lethal dose of vaccinia virus, a relative of smallpox virus, report scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID).

27 Jun 2005

Enzyme known as cathepsin G may be a target for anti-inflammatory treatments

The finding by researchers at Washington University School of Medicine in St. Louis shows that an enzyme known as cathepsin G regulates the ability of immune cells known as neutrophils to secrete chemicals that attract other immune cells and start the local inflammatory process. Over time, the excessive accumulation of immune cells can lead to tissue and cartilage damage in joints, causing pain and limiting mobility.

27 Jun 2005

Expert says the world is not ready for the next pandemic

Michael T. Osterholm is Director of the Center for Infectious Disease Research and Policy, Associate Director of the Department of Homeland Security's National Center for Food Protection and Defense, and Professor at the University of Minnesota's School of Public Health.

21 Jun 2005

Partnership to develop an AIDS vaccine using a promising new technology

GlaxoSmithKline Biologicals (GSK Biologicals) and the International AIDS Vaccine Initiative (IAVI) today announced a public-private partnership to develop an AIDS vaccine using a promising new technology.

21 Jun 2005

Inexpensive tests can be used to decide who needs HIV treatment in poor countries

Researchers from the Johns Hopkins Bloomberg School of Public Health, Centers for Disease Control and Prevention and the Chiang Mai University in Thailand, evaluated the ability of inexpensive biological markers, which are obtainable in resource-poor countries, to determine which HIV-infected patients are in the greatest need of antiretroviral therapy.

20 Jun 2005